Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
29 June 2015 |
Main ID: |
NCT02388035 |
Date of registration:
|
09/03/2015 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Cefotaxime Resistance in Treatment of Spontaneous Bacterial Peritonitis
|
Scientific title:
|
Cefotaxime Resistance in Treatment of Spontaneous Bacterial Peritonitis |
Date of first enrolment:
|
March 2015 |
Target sample size:
|
254 |
Recruitment status: |
Completed |
URL:
|
http://clinicaltrials.gov/show/NCT02388035 |
Study type:
|
Interventional |
Study design:
|
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
|
Phase:
|
N/A
|
|
Countries of recruitment
|
Egypt
| | | | | | | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- patients with liver cirrhosis and ascites and clinical findings suspicious of ascitic
fluid infection
Exclusion Criteria:
- Patients were excluded if they received antibiotics ten days prior to the hospital
admission or there is evidence of secondary bacterial peritonitis, tuberculous
peritonitis, malignant ascites or ascites due to other causes e.g. cardiac or renal
diseases
Age minimum:
N/A
Age maximum:
N/A
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
Spontaneous Bacterial Peritonitis
|
Intervention(s)
|
Drug: Cefotaxime
|
Primary Outcome(s)
|
Organisms detected with their antibiotics sensitivity
[Time Frame: 8 months]
|
Secondary ID(s)
|
HHAEREDS-2015
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|